Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics—An Observational Study

Schizophrenia is a chronic, invalidating, and polymorphic disease, characterized by relapses and remission periods. The main treatment option in schizophrenia are antipsychotics, administered as an oral or as a long-acting injectable (LAI) formulation. Although international guidelines rarely recomm...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ana Aliana Miron, Paula Simina Petric, Andreea Teodorescu, Petru Ifteni, Gabriela Chele, Andreea Silvana Szalontay
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2023-01-01
Saila:	Brain Sciences
Gaiak:	schizophrenia antipsychotics mood stabilizers benzodiazepines
Sarrera elektronikoa:	https://www.mdpi.com/2076-3425/13/2/173
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!